Shiseido New Hair Regeneration Center
More details from the company’s press release.
The company plans to open the Shiseido Cell-Processing and Expansion Center (SPEC) on May 1, 2014. The center will be located in the Kobe Biomedical Innovation Cluster in Kobe, Japan. It will
centralize research and development in regards to hair regenerative medicine, with an end goal toward commercialization.
Shiseido is now also using Canada based Replicel’s RCH-01 dermal sheath cup cell related technology. See: Replicel and Shiseido complete collaboration and technology transfer.
The Japanese government has in the past year made major announcements regarding its support and encouragement of stem cell related research via favorable laws and funding. It will therefore not be surprising if the first hair cloning or hair multiplication type cure comes from that country.
It should be remembered that Japanese car companies and electronics companies significantly improved upon western inventions in those fields. So it would be fitting if a Japanese hair regeneration company significantly improved upon a Western based hair regeneration technology too.
Having said that, it should also be noted that Shiseido also has its own highly experienced team of hair loss research scientists. And a very lengthy history in the hair loss sector.
- Shiseido was founded in 1872 as Japan;s first Western style pharmacy.
- In 1898, the company launched “Euthrixine Hanatsubaki Perfume”.
- In 1915, the hair tonic solution “Flowline” was developed by the company’s scientists.
- In 1982, “Medicated Flowline” was released.
- In 2005, Shiseido released “Medicated Adenogen,” which contained adenosine, a bio-related component, as an active
- Since its release in 2021, the company has sold over 2.3 million units of “The Haircare Adenovital Scalp Essence” throughout Asia.